P. Boström

R. Parkkola, P. Boström, J. Saunavaara, 2018, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept

P. Boström, M. Laato, L. Pylkkänen, 2009, BJU international.

Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.

P. Boström, J. Peltonen, M. Laato, 1999, The American journal of pathology.

SORLA-driven endosomal trafficking regulates the oncogenic fitness of HER2

P. Taimen, P. Boström, I. Paatero, 2018, bioRxiv.

Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review

P. Boström, J. B. Jensen, C. Arum, 2020, Scandinavian journal of urology.

Familial aggregation of testicular cancer among early-onset cancer survivors. A prospective observational cohort data from Finland.

P. Boström, J. Pitkäniemi, N. Malila, 2020, Cancer epidemiology.

Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation

P. Boström, J. Pitkäniemi, N. Malila, 2019, BMC Urology.

Awareness of Smoking as a Risk Factor in Bladder Cancer: Results from the Prospective FinnBladder 9 Trial.

P. Boström, S. Aaltomaa, M. Vaarala, 2022, European urology focus.

Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodology

L. Elo, P. Boström, R. Klén, 2019, Scandinavian journal of urology.

Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study

P. Boström, I. Jambor, A. Rannikko, 2018, BJU international.

Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.

P. Boström, I. Jambor, A. Rannikko, 2017, European urology focus.

Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer

T. H. van der Kwast, A. Zlotta, P. Boström, 2012, BJU international.

EXPRESSION OF CYCLOOXYGENASE‐1 AND‐2 IN URINARY BLADDER CARCINOMAS IN VIVO AND IN VITRO AND PROSTAGLANDIN E 2 SYNTHESIS IN CULTURED BLADDER CANCER CELLS

P. Boström, V. Aaltonen, P. Uotila, 2001, Pathology.

Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial

P. Boström, S. Aaltomaa, M. Vaarala, 2019, World Journal of Urology.

The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression

J. Schleutker, P. Taimen, P. Boström, 2022, Human molecular genetics.

Uptake of 18F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study.

V. Oikonen, M. Scheinin, P. Taimen, 2021, Cancer biotherapy & radiopharmaceuticals.

Mortality after surgery for benign prostate hyperplasia: a nationwide cohort study

P. Boström, V. Kytö, O. Ettala, 2022, World Journal of Urology.

Adverse Events During Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer

L. Elo, P. Boström, R. Klén, 2019, Bladder Cancer.

Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study.

P. Boström, M. Vaarala, T. Murtola, 2018, European urology oncology.

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

P. Taimen, P. Boström, M. Laato, 2014, EMJ Urology.

Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre

P. Boström, M. Laato, T. Mirtti, 2009, Scandinavian journal of urology and nephrology.

Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy.

Y. Lotan, P. Boström, S. Daneshmand, 2016, The Journal of urology.

Integrins are enriched on aberrantly fucosylated tumour‐derived urinary extracellular vesicles

G. Jenster, P. Boström, A. Hendrix, 2022, Journal of extracellular biology.

Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Boström, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.06.

P. Taimen, P. Boström, K. Kettunen, 2019, European urology.

Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019.

P. Boström, J. Pitkäniemi, N. Malila, 2022, Acta oncologica.

Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers

P. Boström, R. Blanco Sequeiros, C. Wright, 2022, Acta radiologica.

Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer

P. Taimen, P. Boström, S. Jalkanen, 2015, PloS one.

Flare on [18F]PSMA-1007 PET/CT after short-term androgen deprivation therapy and its correlation to FDG uptake: possible marker of tumor aggressiveness in treatment-naïve metastatic prostate cancer patients

P. Boström, J. Kemppainen, S. Malaspina, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol

T. Lehtimäki, P. Boström, M. Borre, 2022, BMJ Open.

A comparison of survival and mortality outcomes for older men with localized prostate cancer treated with either primary androgen deprivation therapy or primary observation

P. Boström, J. Pitkäniemi, N. Malila, 2019 .

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results

P. Taimen, P. Boström, J. Saunavaara, 2020, European urology open science.

Which data are available in central registries on bladder cancer patients in the five Nordic countries

P. Boström, J. B. Jensen, S. Gudjonsson, 2021, Scandinavian journal of urology.

Incidence of and mortality from Bacille Calmette‐Guérin (BCG) infections after BCG instillation therapy

P. Boström, O. Ettala, A. Kaipia, 2021, BJU international.

Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study.

P. Boström, S. Aaltomaa, E. Kaasinen, 2016, European urology.

Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer

P. Boström, T. Tuokkola, J. Kemppainen, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Magnetic resonance imaging‐guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12‐month clinical outcomes of a phase I study

P. Taimen, P. Boström, R. Blanco Sequeiros, 2021, BJU international.

Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy

Mikael Lundin, Johan Lundin, Antti Rannikko, 2016, Modern Pathology.

Genomic Predictors of Outcome in Prostate Cancer.

M. Cooperberg, T. Schlomm, H. Lilja, 2015, European urology.

– Prostate Cancer Genomic Predictors of Outcome in Prostate Cancer

M. Cooperberg, T. Schlomm, H. Lilja, 2015 .

Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates

P. Taimen, P. Boström, K. Pettersson, 2015, BMC Urology.

Time trends and occupational variation in the incidence of testicular cancer in the Nordic countries

P. Boström, E. Pukkala, S. Jyrkkiö, 2018, BJU international.

ANO7 is associated with aggressive prostate cancer

J. Schleutker, T. Tammela, F. Wiklund, 2018, International journal of cancer.

SORLA regulates endosomal trafficking and oncogenic fitness of HER2

P. Taimen, P. Boström, H. Joensuu, 2019, Nature Communications.

A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primar

P. Dean, P. Taimen, P. Boström, 2020, European urology oncology.

Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.

T. Tammela, M. Matikainen, P. Boström, 2019, European urology.

Clinical presentation of bacille Calmette–Guérin (BCG) infections after BCG instillation therapy

P. Boström, O. Ettala, A. Kaipia, 2022, BJU international.

Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate

Pekka Taimen, Kim Pettersson, Peter J Boström, 2016, BMC Urology.

ANO7 rs77559646 Is Associated With First-line Docetaxel Treatment Response in Metastatic Castration-resistant Prostate Cancer

J. Schleutker, P. Taimen, P. Boström, 2019, AntiCancer Research.

Kinetic analysis and optimisation of 18F-rhPSMA-7.3 PET imaging of prostate cancer

V. Oikonen, M. Scheinin, P. Boström, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy

Laura L. Elo, Peter J. Boström, Teemu D. Laajala, 2016, Scientific Reports.

Intratumoral androgen levels are linked to TMPRSS2-ERG fusion in prostate cancer.

L. Elo, P. Taimen, P. Boström, 2018, Endocrine-related cancer.

A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma

T. Laajala, L. Elo, P. Boström, 2021, Scientific Reports.

Critical evaluation of the subcutaneous engraftments of hormone naïve primary prostate cancer

L. Elo, P. Taimen, P. Boström, 2020, Translational andrology and urology.

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression

P. Taimen, P. Boström, P. Härkönen, 2022, Cancers.

Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy

P. Taimen, P. Boström, P. Härkönen, 2016, International journal of cancer.

Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer

P. Taimen, P. Boström, T. Mirtti, 2021, Scientific Reports.

Tournament leave-pair-out cross-validation for receiver operating characteristic analysis

Tapio Pahikkala, Antti Airola, Ivan Jambor, 2018, Statistical methods in medical research.

Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised Fi

P. Boström, S. Aaltomaa, M. Vaarala, 2015, European urology.

Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression

Pekka Taimen, Peter J. Boström, Tuomas Mirtti, 2015, PloS one.

Reply from authors re: Robert S. Svatek. Long-term outcomes of the FinnBladder-4 study. Eur Urol 2015;68:618-9: which type of maintenance matters?

P. Boström, E. Kaasinen, R. Järvinen, 2015, European urology.

Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial)

P. Dean, H. Merisaari, P. Taimen, 2017, Journal of magnetic resonance imaging : JMRI.

Accurate Prostate Cancer Detection and Segmentation on Biparametric MRI using Non-local Mask R-CNN with Histopathological Ground Truth pdf

Hannu J. Aronen, Harri Merisaari, Ivan Jambor, 2020, ArXiv.

Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)

H. Merisaari, Marko Pesola, P. Taimen, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole‐mount prostatectomy sections and implications for focal therapy

Tapio Pahikkala, Jani Saunavaara, Harri Merisaari, 2019, Journal of magnetic resonance imaging : JMRI.

Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer

H. Merisaari, P. Taimen, P. Boström, 2021, Journal of magnetic resonance imaging : JMRI.

Optimal timing of radical cystectomy in T1 high-grade bladder cancer

A. Zlotta, P. Boström, C. Kuk, 2010, Expert review of anticancer therapy.

Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells.

P. Taimen, P. Boström, M. Poutanen, 2019, European urology.

Non-muscle-invasive bladder cancer: a vision for the future

P. Boström, P. Malmström, G. Hermann, 2017, Scandinavian journal of urology.

Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men

P. Taimen, P. Boström, H. Aronen, 2020, Scandinavian journal of urology.

New prostate cancer grade grouping system predicts survival after radical prostatectomy.

P. Taimen, P. Boström, S. Nordling, 2018, Human pathology.

11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)

H. Merisaari, P. Taimen, P. Boström, 2018, Cancer Imaging.

Deep learning prediction of non-perfused volume without contrast agents during prostate ablation therapy

P. Boström, R. Blanco Sequeiros, C. Wright, 2022, Biomedical Engineering Letters.

Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer

P. Boström, S. Jalkanen, M. Tervahartiala, 2018, Carcinogenesis.

Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques

P. Taimen, P. Boström, R. Blanco Sequeiros, 2022, Frontiers in Oncology.

Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization

Tapio Pahikkala, Jussi Toivonen, Harri Merisaari, 2019, PloS one.

Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort

Nathan Lawrentschuk, Theodorus H van der Kwast, Antonio Finelli, 2011, BJU international.

A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.

P. Warde, P. Boström, Philippe Bédard, 2018, European urology focus.

MRI-guided transurethral ultrasound ablation for BPH: 12-month clinical outcomes of a phase I study.

P. Taimen, P. Boström, J. Saunavaara, 2021, BJU international.

Stratification of aggressive prostate cancer from indolent disease-Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue.

Ivan Jambor, Matthias Nees, Pekka Taimen, 2016, Urologic oncology.

Stage-specific mortality and survival trends of prostate cancer patients in Finland before and after introduction of PSA

P. Boström, J. Pitkäniemi, N. Malila, 2017, Acta oncologica.

Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette‐Guérin (BCG) treatment

P. Taimen, P. Boström, O. Ettala, 2018, BJU international.

Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer

P. Taimen, P. Boström, R. Blanco Sequeiros, 2020, Acta radiologica.

Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer

P. Taimen, P. Boström, J. Saunavaara, 2019, Scandinavian journal of urology.

Interferon-alpha inhibits cyclooxygenase-1 and stimulates cyclooxygenase-2 expression in bladder cancer cells in vitro.

P. Boström, M. Laato, I. Huhtaniemi, 2001, Urological research.

Initiation of robot-assisted radical prostatectomies in Finland: Impact on centralization and quality of care

M. Matikainen, P. Boström, A. Rannikko, 2016, Scandinavian journal of urology.

Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study.

H. Merisaari, P. Taimen, P. Boström, 2020, European urology oncology.

Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI‐Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI‐IMPROD Trials)

H. Merisaari, P. Taimen, P. Boström, 2019, Journal of magnetic resonance imaging : JMRI.

Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial

H. Merisaari, P. Taimen, P. Boström, 2019, PLoS medicine.

Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy

I. Tannock, A. Zlotta, P. Boström, 2016, Bladder cancer.

Progress towards a Nordic standard for the investigation of hematuria: 2019

P. Boström, P. Malmström, J. Bjerggaard Jensen, 2019, Scandinavian journal of urology.

Visual MRI T-category versus VI-RADS evaluation from multiparametric MRI in the detection of muscle-invasion in patients with suspected bladder cancer: single centre registered clinical trial (MIB-trial)

H. Merisaari, P. Taimen, P. Boström, 2021, Scandinavian journal of urology.

Histopathological evaluation of prostate specimens after thermal ablation may be confounded by the presence of thermally-fixed cells

P. Taimen, P. Boström, R. Blanco Sequeiros, 2019, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Comparison of Bacillus Calmette-Guérin Maintenance Therapy with Monthly Instillations and the Southwest Oncology Group Protocol in the Treatment of Non-muscle-invasive Bladder Cancer.

P. Boström, O. Ettala, A. Kaipia, 2023, European urology focus.

How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database

H. Merisaari, P. Taimen, P. Boström, 2021, Acta radiologica open.

Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction

H. Merisaari, Marko Pesola, P. Taimen, 2016, Magnetic resonance in medicine.

Clinical Utility of Mutant Antibody-Based Assays for Determination of Internally Cleaved and Intact Forms of Free Prostate-Specific Antigen.

P. Taimen, P. Boström, K. Pettersson, 2019, The journal of applied laboratory medicine.

The composition of prostate core matrisome in vivo and in vitro unveiled by mass spectrometric analysis

J. Heino, P. Taimen, P. Boström, 2018, The Prostate.

Evolution of non-perfused volume after transurethral ultrasound ablation of prostate: A retrospective 12-month analysis

P. Boström, R. Sequeiros, C. Wright, 2023, European journal of radiology open.

Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer

P. Dean, P. Taimen, P. Boström, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Decreased forced expiratory volume in first second is associated with erectile dysfunction in apparently healthy men. A preliminary study.

P. Boström, T. Vahlberg, T. Saaresranta, 2019, International Journal of Impotence Research.

Erectile dysfunction cannot be used in primary screening of pre-diabetes.

P. Boström, T. Vahlberg, P. Aarnio, 2015, Diabetes research and clinical practice.

690 NERVE-SPARING RADICAL PROSTATECTOMY IN SELECTED HIGH-RISK AND LOCALLY ADVANCED PROSTATE CANCERS IS ASSOCIATED WITH LOW POSITIVE MARGIN RATES USING A COMBINATION OF PREOPERATIVE MRI, SPECIAL INSTRUMENTATION AND INTRA-OPERATIVE FROZEN SECTIONS

A. Evans, N. Lawrentschuk, P. Boström, 2010 .

Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Study That Challenges the Dogma

F. Montorsi, R. V. D. van den Bergh, P. Boström, 2023, The Journal of urology.

Patient‐specific pharmacokinetic parameter estimation on dynamic contrast‐enhanced MRI of prostate: Preliminary evaluation of a novel AIF‐free estimation method

A. Madabhushi, H. Merisaari, P. Taimen, 2016, Journal of magnetic resonance imaging : JMRI.

Relaxation along fictitious field, diffusion‐weighted imaging, and T2 mapping of prostate cancer: Prediction of cancer aggressiveness

H. Merisaari, Marko Pesola, P. Taimen, 2016, Magnetic resonance in medicine.

Diffusion-weighted imaging of prostate cancer: effect of b-value distribution on repeatability and cancer characterization.

Jussi Toivonen, H. Merisaari, Marko Pesola, 2015, Magnetic resonance imaging.

Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies

Matthias Nees, Pekka Taimen, Kim Pettersson, 2016, PloS one.

Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer

P. Taimen, P. Boström, R. Blanco Sequeiros, 2020, Scandinavian journal of urology.

Prediction of prostate cancer aggressiveness using 18F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI

H. Merisaari, Marko Pesola, P. Taimen, 2020, Scientific Reports.

765 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER

Y. Lotan, A. Sagalowsky, R. Ashfaq, 2011 .

Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies.

H. Merisaari, P. Taimen, P. Boström, 2020, European urology focus.

Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study

David I. Lee, T. Rebbeck, A. Tewari, 2021, npj Precision Oncology.

Incidence, characteristics, and implications of thrombo-embolic events in patients with urothelial carcinoma of the bladder undergoing neoadjuvant chemotherapy.

Y. Lotan, P. Boström, S. Daneshmand, 2016 .

Prostate cancer detection and segmentation on MRI using non-local mask R-CNN with histopathological ground truth.

H. Merisaari, P. Taimen, P. Boström, 2023, Medical physics.

Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer

H. Merisaari, P. Taimen, P. Boström, 2019, EJNMMI Research.

Gut microbiota signatures associate with prostate cancer risk

L. Elo, P. Taimen, P. Boström, 2021, medRxiv.

MP60-12 MULTI-INSTITUTIONAL QUALITY CARE INITIATIVE TO IMPROVE THE CARE OF PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER

P. Black, M. Gleave, A. Kibel, 2014 .

Detection of prostate cancer bone metastases with fast whole-body 99mTc-HMDP SPECT/CT using a general-purpose CZT system

P. Boström, T. Noponen, M. Seppänen, 2022, EJNMMI Physics.

Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer

P. Boström, I. Jambor, A. Sohlberg, 2022, Nuclear medicine communications.

SORLA regulates endosomal trafficking and oncogenic fitness of HER2

P. Taimen, P. Boström, H. Joensuu, 2019, Nature Communications.

Bulbourethral gland adenocarcinoma in a 25-year-old man without comorbidities: Radical resection of proximal urethrae with Mitrofanoff-type appendicovesicostomy

P. Taimen, P. Boström, K. Syvänen, 2014, Scandinavian journal of urology.

Vasectomy and the risk of prostate cancer in a Finnish nationwide population-based cohort.

P. Boström, J. Pitkäniemi, N. Malila, 2019, Cancer epidemiology.

Tournament leave-pair-out cross-validation for receiver operating characteristic analysis

P. Boström, T. Pahikkala, I. Jambor, 2018, Statistical methods in medical research.

Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy.

P. Taimen, P. Boström, M. Laato, 2014, Urologic oncology.

Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland

P. Boström, M. Vaarala, T. Murtola, 2023, Acta oncologica.

Short- and long-term risks of photoselective laser vaporization of the prostate: a population-based comparison with transurethral resection of the prostate

P. Boström, V. Kytö, O. Ettala, 2023, Annals of medicine.

1H-NMR-based urine metabolomics of prostate cancer and benign prostatic hyperplasia

P. Taimen, P. Boström, T. Huynh, 2024, Heliyon.